Antimycobacterial natural products - An opportunity for the Colombian biodiversity;Productos naturales antimicobacterianos: Una oportunidad para la biodiversidad Colombiana

Revista Espanola de Quimioterapia

Volumn 24, Issue 4, 2011, Pages 175-183

  Bueno, Juan ^a,b   David Coy, Ericsson ^c   Stashenko, Elena ^d  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b Centro Colombiano de Investigación en Tuberculosis CCITB   (Colombia)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

Antimycobacterial activity; Colombia biodiversity; Natural products

Indexed keywords

12 METHYL 5 DEHYDROACETYLHORMINONE; 8 HYDROXYMANZAMINE A; AMIKACIN; ANTIINFECTIVE AGENT; AXISONITRILE 3; CALANOLIDE A; CAPREOMYCIN; CECROPIN; ENGELHARDIONE; EROGORGIAENE; IRCINOL A; KANAMYCIN; LITOSTEROL; MANZAMINE A; MELITTIN; MULINANE; NATURAL PRODUCT; OLEANOLIC ACID; PHYTANOL; PHYTOL; PSEUDOPTEROXAZOLE; PUUPEHENONE; RIFAMYCIN; SARINGOSTEROL; STREPTOMYCIN; THIOLACTOMYCIN; TRYPTANTHRIN; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; BIODIVERSITY; COLOMBIA; DISEASE TRANSMISSION; DRUG DETERMINATION; DRUG STRUCTURE; HUMAN; INSECT; MICROORGANISM; MYCOSIS; NONHUMAN; PAIN; RELAPSE; REVIEW; TUBERCULOSIS CONTROL;

ANIMALS; ANTITUBERCULAR AGENTS; BIODIVERSITY; BIOLOGICAL AGENTS; COLOMBIA; FUNGI; HUMANS; INSECTS; MARINE BIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PLANTS; TUBERCULOSIS;

EID: 84856057197     PISSN: 02143429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Ducati R G, Ruffino-Netto A, Basso L A, Santos D S. The resumption of consumption- a review on tuberculosis. Mem Inst Oswaldo Cruz 2006; 101: 697-714.
2. Zumla A, Grange J. Tuberculosis. BMJ 1998; 316: 1962-4.
3. Chang-Blanc D, Nunn P. Incentives and Disincentives for New Anti-Tuberculosis Drug Development. World Health Organization, Geneva, Switzerland, 1999.
4. National Institute of Allergy and Infectious Diseases/NIAID. NIAID Global Health Research Plan for HIV/AIDS, Malaria, and Tuberculosis. National Institute of Allergy and Infectious Diseases, Bethesda, USA, 2001.
5. O'Brien R J, Nunn P P. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. Am J Respir Crit Care Med 2001; 163: 1055-8.
6. Janin YL. Antituberculosis drugs: ten years of research. Bioorg Med Chem 2007; 15: 2479-513.
7. Barry PJ, O'Connor TM. Novel agents in the management of Mycobacterium tuberculosis disease. Curr Med Chem 2007; 14: 2000-8.
8. Harvey A L. Natural products as a screening resource. Curr Opin Chem Biol 2007; 11: 480-4.
9. Butler MS. Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 2005; 22: 162-95.
10. Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005; 4: 206-20.
11. Chin YW, Balunas MJ, Chai HB, Kinghorn AD. Drug discovery from natural sources. AAPS J 2006; 8: E239-53.
12. Pauli GF, Case RJ, Inui T, Wang Y, Cho S, Fischer NH, Franzblau SG. New perspectives on natural products in TB drug research. Life Sci 2005; 78: 485-94.
13. Copp BR, Pearce AN. Natural product growth inhibitors of Mycobacterium tuberculosis. Nat Prod Rep 2007; 24: 278-97.
14. Okunade AL, Elvin-Lewis MP, Lewis WH. Natural antimycobacterial metabolites: current status. Phytochemistry 2004; 65: 1017-32.
15. Heinrich M, Gibbons S. Ethnopharmacology in drug discovery: an analysis of its role and potential contribution. J Pharm Pharmacol 2001; 53: 425-32.
16. Gautam R, Saklani A, Jachak SM. Indian medicinal plants as a source of antimycobacterial agents. J Ethnopharmacol 2007; 110: 200-34.
17. Gibbons S. Phytochemicals for Bacterial Resistance - Strengths, Weaknesses and Opportunities. Planta Med 2008; 74:594-602.
18. Jain RC. Anti tubercular activity of garlic oil. Indian J Pathol Microbiol 1998; 41: 131.
19. Cantrell CL, Lu T, Fronczek FR, Fischer NH, Adams LB, Franzblau SG. Antimycobacterial cycloartanes from Borrichia frutescens. J Nat Prod 1996; 59: 1131-6.
20. Appendino G, Mercalli E, Fuzzati N, Arnoldi L, Stavri M, Gibbons S, Ballero M, Maxia A. Antimycobacterial coumarins from the sardinian giant fennel (Ferula communis). J Nat Prod 2004; 67: 2108-10.
21. Newton SM, Lau C, Wright CW. A review of antimycobacterial natural products. Phytother Res 2000; 14: 303-22.
22. Rajab MS, Cantrell CL, Franzblau SG, Fischer NH. Antimycobacterial activity of (E)-phytol and derivatives: a preliminary structure- activity study. Planta Med 1998; 64: 2-4.
23. Ulubelen A, Topcu G, Johansson C B. Norditerpenoids and diterpenoids from Salvia multicaulis with antituberculous activity. J Nat Prod 1997; 60: 1275-80.
24. Mitscher LA, Baker W. Tuberculosis: a search for novel therapy starting with natural products. Med Res Rev 1998; 18: 363-74.
25. Graham JG, Pendland SL, Prause JL, Danzinger LH, Schunke Vigo J, Cabieses F, Farnsworth NR. Antimycobacterial evaluation of Peruvian plants. Phytomedicine 2003; 10: 528-35.
26. Jimenez-Arellanes A, Meckes M, Torres J, Luna-Herrera J. Antimycobacterial triterpenoids from Lantana hispida (Verbenaceae). J Ethnopharmacol 2007; 111: 202-5.
27. Camacho-Corona M del R, Ramirez-Cabrera M A, Santiago OG, Garza-Gonzalez E, Palacios I de P, Luna-Herrera J. Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases. Phytother Res 2008; 22: 82-5.
28. Wachter GA, Franzblau SG, Montenegro G, Suarez E, Fortunato R H, Saavedra E,Timmermann BN. A new antitubercular mulinane diterpenoid from Azorella madreporica Clos. J Nat Prod 1998; 61: 965-8.
29. Xu ZQ, Barrow WW, Suling WJ, Westbrook L, Barrow E, Lin YM, Flavin MT. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis. Bioorg Med Chem 2004; 12: 1199-207.
30. Thangadurai D, Viswanathan MB, Ramesh N. Indigoferabietone, a novel abietane diterpenoid from Indigofera longeracemosa with potential antituberculous and antibacterial activity. Pharmazie 2002; 57:714-15.
31. Wächter GA, Franzblau SG, Montenegro G, Hoffmann JJ, Maiese WM, Timmermann BN. Inhibition of Mycobacterium tuberculosis growth by saringosterol from Lessonia nigrescens. J Nat Prod 2001, 64:1463-4.
32. Lin W-Y, Peng C-F, Tsai I-L, Chen J-J, Cheng M-J, Chen I-S. Antitubercular constituents from the roots of Engelhardia roxburghiana. Planta medica 2005; 71:171-5.
33. Donia M, Hamann MT. Marine natural products and their potential applications as anti-infective agents. Lancet Infect Dis 2003; 3: 338-48.
34. Ichiba T, Corgiat JM, Scheuer PJ, Kelly-Borges M. 8-Hydroxymanzamine A, a beta-carboline alkaloid from a sponge, Pachypellina sp. J Nat Prod 1994; 57: 168-70.
35. Yousaf M, Hammond NL, Peng J, Wahyuono S, McIntosh KA, Charman WN, Mayer AM, Hamann MT. New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases. J Med Chem 2004; 47: 3512-7.
36. Konig GM, Wright AD, Franzblau SG. Assessment of antimycobacterial activity of a series of mainly marine derived natural products. Planta Med 2000; 66: 337-42.
37. Rodriguez AD, Ramirez C, Rodriguez II, Gonzalez E. Novel antimycobacterial benzoxazole alkaloids, from the west Indian Sea whip Pseudopterogorgia elisabethae. Org Lett 1999; 1: 527-30.
38. Rodriguez AD, Ramirez C. Serrulatane diterpenes with antimycobacterial activity isolated from the West Indian sea whip Pseudopterogorgia elisabethae. J Nat Prod 2001; 64: 100-2.
39. Iguchi K, Saitoh S, Yamada Y. Novel 19-oxygenated sterols from the Okinawan soft coral Litophyton viridis. Chem Pharm Bull 1989; 37: 2553-4.
40. Capon RJ, Barrow RA, Rochfort S, Jobling M, Skene C, Lacey EH, Gill J, Friedel T, Wadsworth D. Marine nematocides: Tetrahydrofurans from a southern Australian brown alga, Notheia anomala. Tetrahedron 1998; 54: 2227-42.
41. Broekaert WF, Terras FR, Cammue BP, Osborn RW. Plant defensins: novel antimicrobial peptides as components of the host defense system. Plant Physiol 1995; 108: 1353-8.
42. Andreu D, Rivas L. Animal antimicrobial peptides: an overview. Biopolymers 1998; 47: 415-33.
43. Kuhn-Nentwig L. Antimicrobial and cytolytic peptides of venomous arthropods. Cell Mol Life Sci 2003; 60: 2651-68.
44. Corzo G, Escoubas P. Pharmacologically active spider peptide toxins. Cell Mol Life Sci 2003; 60: 2409-26.
45. Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1999; 1462: 1-10.
46. Giangaspero A, Sandri L, Tossi A. Amphipathic alpha helical antimicrobial peptides. Eur J Biochem 2001; 268: 5589-600.
47. Zerbini E, Andreu D, Tonarelli G, Sequeira MD. In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria. Rev Argent Microbiol 2006; 38: 221-3.
48. Harvey A. Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 2000; 5: 294-300.
49. Davies J. In the Beginning There Was Streptomycin. In: D. P. Arya (Ed.). Aminoglycoside Antibiotics. John Wiley & Sons, Inc, New Jersey 2007; 1-13.
50. Tripathi RP, Tewari N, Dwivedi N, Tiwari VK. Fighting tuberculosis: an old disease with new challenges. Med Res Rev 2005; 25: 93-131.
51. Miyakawa S, Suzuki K, Noto T, Harada Y, Okazaki H. Thiolactomycin a new antibiotic. IV. Biological properties and chemotherapeutic activity in mice. J Antibiot (Tokyo) 1982; 35: 411-9.
52. Ministerio del Medio Ambiente, Departamento Nacional de Planeación and Instituto Alexander Von Humboldt. Política nacional de biodiversidad. República de Colombia, 1997.
53. Lopez A, Hudson JB, Towers GH. Antiviral and antimicrobial activities of Colombian medicinal plants. J Ethnopharmacol 2001; 77: 189-96.
54. Bueno-Sanchez JG, Martinez-Morales JR, Stashenko EE, Ribon W. Anti-tubercular activity of eleven aromatic and medicinal plants occurring in Colombia. Biomedica 2009;29:51-60.
55. Coy ED, Cuca LE, Sefkow M. Macrophyllin-type bicyclo[3.2.1]octanoid neolignans from the leaves of Pleurothyrium cinereum. J Nat Prod 2009;72:1245-8.
56. Ospina C, Rodríguez A, Zhao H, Raptis R. Bipinnapterolide B, a bioactive oxapolycyclic diterpene from the Colombian gorgonian coral Pseudopterogorgia bipinnata. Tetrahedron Letters 2007;48:7520-23.
57. Rodríguez I, Rodríguez A, Wang Y, Franzblau S. Ileabethoxazole: a novel benzoxazole alkaloid with antimycobacterial activity. Tetrahedron Letters 2006;47:3229-32.
58. World Health Organization. Traditional medicine. World Health Organization, Geneva, Switzerland, 2002.
59. Instituto de Investigación de Recursos Biológicos Alexander Von Humboldt. Encuesta Nacional de Plantas Medicinales y Aromáticas una Aproximación al Mercado de las Pmya en Colombia. Instituto Alexander Von Humboldt, Villa de Leyva, Colombia, 2000.
60. McMannis C. Biodiversity, Biotechnology and Traditional Knowledge Protection: Law, Science and Practice. In: McMannis C. (Ed.). Biodiversity and the Law. Earthscan, London 2007; 1-26.